Skip to content

ITI Dental Implant System SLA Titanium TL (REF 043.763S)Recalls & reported problems

Institut Straumann AG · Tapered Effect Implant, D 4.1mm, RN, SLA 12mm, Ti · Class 2 · Implant

All models of ITI DENTAL IMPLANT SYSTEM (60)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

This Straumann ITI dental implant is placed in the jawbone. Its 251 reports often describe the implant losing its bond with the bone, and some mention infection, swelling and bleeding. The reports include 251 injuries and no deaths. No recalls name this device.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
252
Deaths reported
0
Injuries reported
252
Recalls naming it
0

Summary

The FDA's MAUDE database contains 252 adverse event reports that list this exact device (DI 07630031701091), received between Sep 9, 2019 and Sep 10, 2026 — classified as 252 injuries.

The most frequently reported specific device problem is “Loss of Osseointegration” (191 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 3 reportsDec 2023: 5 reportsJan 2024: 0 reportsFeb 2024: 11 reportsMar 2024: 1 reportsApr 2024: 3 reportsMay 2024: 3 reportsJun 2024: 4 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 3 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 1 reportsMar 2025: 6 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 10 reportsJul 2025: 1 reportsAug 2025: 3 reportsSep 2025: 1 reportsOct 2025: 2 reportsNov 2025: 1 reportsDec 2025: 4 reportsJan 2026: 3 reportsFeb 2026: 2 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 2 reportsJun 2026: 1 reportsJul 2026: 2 reportsAug 2026: 1 reportsSep 2026: 1 reportsOct 2026: 0 reports20242025202611
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Loss of Osseointegration191
  • Failure to Osseointegrate61
  • Fracture3
  • Adverse Event Without Identified Device or Use Problem1
  • Unintended Movement1

Patient problems

  • Unspecified Infection97
  • Fibrosis78
  • No Clinical Signs, Symptoms or Conditions58
  • Pain58
  • Hemorrhage/Blood Loss/Bleeding49
  • Tissue Damage46
  • Inflammation38
  • Swelling/ Edema35

Recent adverse event reports

The 25 most recent of 252 reports, in the reporter's own words as published by the FDA.

  • InjurySep 10, 2026Loss of Osseointegration

    Patient problems: Hemorrhage/Blood Loss/Bleeding; Inflammation; Swelling/ Edema; Unspecified Infection

    MAUDE report 50719715 ↗
  • InjuryAug 3, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (b)(6) 2010 in the patient's mouth. On (b)(6) 2026, loss of osseointegration was verified. The device was forwarded to the manufacturer. There were no patient operative or post-operative complications reported.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50118893 ↗
  • InjuryJul 13, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2006 IN FDI 25. ON (B)(6) 2026, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS AND MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Unspecified Infection

    MAUDE report 25801017 ↗
  • InjuryJul 13, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2007 IN FDI 33. ON (B)(6) 2026, LOSS OF OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH BONE TYPE III. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: INFLAMMATION. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Inflammation

    MAUDE report 25800286 ↗
  • InjuryJun 12, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2005, IN FDI 26. ON (B)(6) 2026, LOSS OF OSSEOINTEGRATION WAS VERIFIED. NO PRODUCT WAS RETURNED TO THE MANUFACTURER. THERE WERE NO PATIENT OPERATIVE OR POST-OPERATIVE COMPLICATIONS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25490063 ↗
  • InjuryMay 26, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2005 IN ADA 6. DETAILS OF SURGERY: RIDGE AUGMENTATION. ON (B)(6) 2026, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: SWELLING AND INFLAMMATION. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Inflammation; Swelling/ Edema

    MAUDE report 25284459 ↗
  • InjuryMay 26, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2005 IN ADA 6. DETAILS OF SURGERY: RIDGE AUGMENTATION. ON (B)(6) 2026, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: SWELLING AND INFLAMMATION. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Inflammation; Swelling/ Edema

    MAUDE report 25282544 ↗
  • InjuryMar 30, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2005 IN THE PATIENT'S MOUTH. ON (B)(6) 2026, LOSS OF OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH FAIR ORAL HYGIENE. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: INFECTION, PERI-IMPLANTITIS, SWELLING, ABSCESS AND FISTULA. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Abscess; Fistula; Swelling/ Edema; Unspecified Infection

    MAUDE report 24718180 ↗
  • InjuryFeb 23, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2018 IN THE PATIENT'S MOUTH. ON (B)(6) 2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH BONE TYPE III AND POOR ORAL HYGIENE. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS AND MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Unspecified Infection

    MAUDE report 24419779 ↗
  • InjuryFeb 9, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2009 IN FDI 16. DETAILS OF SURGERY: SINUS AUGMENTATION. ON (B)(6) 2026, LOSS OF OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH BONE TYPE III. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS, MOBILITY AND SWELLING. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Swelling/ Edema; Unspecified Infection

    MAUDE report 24295252 ↗
  • InjuryJan 16, 2026Fracture

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2025 IN THE PATIENT'S MOUTH. ON (B)(6) 2025, FRACTURE OF THE IMPLANT WAS VERIFIED. NO PRODUCT WAS RETURNED TO THE MANUFACTURER. THERE WERE NO PATIENT OPERATIVE OR POST-OPERATIVE COMPLICATIONS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24098908 ↗
  • InjuryJan 12, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6)2008 IN THE PATIENT'S MOUTH. ON (B)(6)2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. THERE WERE NO PATIENT OPERATIVE OR POST-OPERATIVE COMPLICATIONS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24042004 ↗
  • InjuryJan 5, 2026Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED ON (B)(6) 2006 IN FDI 45. ON (B)(6) 2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH POOR ORAL HYGIENE. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PAIN, MOBILITY AND BLEEDING. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Hemorrhage/Blood Loss/Bleeding; Pain

    MAUDE report 23962965 ↗
  • InjuryDec 29, 2025Loss of Osseointegration; Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2020 IN FDI 46. ON (B)(6) 2024, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. THERE WERE NO PATIENT OPERATIVE OR POST-OPERATIVE COMPLICATIONS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23914280 ↗
  • InjuryDec 16, 2025Fracture; Failure to Osseointegrate; Fracture; Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2025 IN THE PATIENT'S MOUTH. ON (B)(6) 2025, NON-OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. THERE WERE NO REPORTED PATIENT INJURIES OR COMPLICATIONS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23819521 ↗
  • InjuryDec 12, 2025Loss of Osseointegration; Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2013 IN FDI 36. ON (B)(6) 2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Unspecified Infection

    MAUDE report 23792545 ↗
  • InjuryDec 5, 2025Failure to Osseointegrate; Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2025 IN FDI 16. ON (B)(6) 20255, NON-OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. THERE WERE NO REPORTED PATIENT INJURIES OR COMPLICATIONS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23731711 ↗
  • InjuryNov 13, 2025Loss of Osseointegration; Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2007 IN FDI 23. ON (B)(6) 2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH BONE TYPE III AND FAIR ORAL HYGIENE. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS AND MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Unspecified Infection

    MAUDE report 23545443 ↗
  • InjuryOct 20, 2025Loss of Osseointegration; Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2022 IN FDI 15. DETAILS OF SURGERY: IMPLANT SURFACE NOT COMPLETELY COVERED WITH BONE AND IMMEDIATE EXTRACTION SITE. ON (B)(6) 2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH BONE TYPE IV AND FAIR ORAL HYGIENE. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: INFECTION, PERI-IMPLANTITIS, MOBILITY, BLEEDING, FISTULA AND INFLAMMATION. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Fistula; Hemorrhage/Blood Loss/Bleeding; Inflammation; Unspecified Infection

    MAUDE report 23339340 ↗
  • InjuryOct 17, 2025Loss of Osseointegration; Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2009 IN FDI 16. (B)(6) 2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS AND MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Unspecified Infection

    MAUDE report 23326443 ↗
  • InjurySep 12, 2025Loss of Osseointegration; Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2011 IN FDI 26. ON (B)(6) 2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH PREVIOUS BONE AUGMENTATION. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PERI-IMPLANTITIS, SWELLING AND BLEEDING. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Hemorrhage/Blood Loss/Bleeding; Swelling/ Edema; Unspecified Infection

    MAUDE report 23040965 ↗
  • InjuryAug 11, 2025Loss of Osseointegration; Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2016 IN FDI 16. ON (B)(6) 2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH BONE TYPE III. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis

    MAUDE report 22775603 ↗
  • InjuryAug 4, 2025Loss of Osseointegration; Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2011 IN FDI 13. ON (B)(6) 2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis

    MAUDE report 22705506 ↗
  • InjuryAug 4, 2025Loss of Osseointegration; Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2006 IN FDI 23. ON (B)(6) 2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH FAIR ORAL HYGIENE. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PAIN AND MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Pain

    MAUDE report 22705339 ↗
  • InjuryJul 15, 2025Loss of Osseointegration; Loss of Osseointegration

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2011 IN FDI 16. ON (B)(6) 2025, LOSS OF OSSEOINTEGRATION WAS VERIFIED. NO PRODUCT WAS RETURNED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PAIN, MOBILITY AND BLEEDING. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Hemorrhage/Blood Loss/Bleeding; Pain

    MAUDE report 22510634 ↗

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page